Clinical Trial Update: Lingual Nerve Disruption to Augment Neoadjuvant Chemoimmunotherapy in Locally Advanced Tongue Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update exploring lingual nerve disruption to augment neoadjuvant chemoimmunotherapy for locally advanced tongue squamous cell carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tongue Squamous Cell Carcinoma

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Tongue Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING